Conference after conference, Roche scientists running the ongoing Brain Shuttle AD trial of trontinemab are dispensing ...

The blood-brain barrier border protects the brain by regulating the flow of molecules, peptides, and cells, but it also keeps ...

REAL AD hints that blood markers can spot subtle cognitive decline. People who fluff a digital cognitive test have more ...

In addition, Eisai must conduct a post-authorization safety study, including setting up a patient registry for the European Union. Now each European country must set its own rules for access and ...

The association between vaccination against the herpes zoster (HZ) virus, which causes shingles, and dementia risk continues to gain traction. Earlier this month, Pascal Geldsetzer and his team at ...

As lecanemab gains regulatory approval in more countries (see previous story), clinicians are eager to learn from the first centers to have incorporated this therapeutic antibody into their clinical ...

As the trained killers of the immune system, cytotoxic T cells silently save our lives every day—vanquishing viruses before they can run amok, and putting nascent cancer cells out of business before ...

On April 15, two years after Eisai requested a marketing license for lecanemab in Europe, the European Commission has greenlit its use. The biologic’s long path included an initial rejection from the ...